Neuronal activity and glutamate uptake decrease mitochondrial mobility in astrocytes and position mitochondria near glutamate transporters.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 3905137)

Published in J Neurosci on January 29, 2014

Authors

Joshua G Jackson1, John C O'Donnell, Hajime Takano, Douglas A Coulter, Michael B Robinson

Author Affiliations

1: Children's Hospital of Philadelphia Research Institute, Department of Pediatrics, Department of Pharmacology, and Department of Neuroscience, University of Pennsylvania, Philadelphia, Pennsylvania 19104.

Articles citing this

Glucose, lactate, and shuttling of metabolites in vertebrate retinas. J Neurosci Res (2015) 0.97

Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis (2015) 0.88

Reciprocal Regulation of Mitochondrial Dynamics and Calcium Signaling in Astrocyte Processes. J Neurosci (2015) 0.88

Miro1 Regulates Activity-Driven Positioning of Mitochondria within Astrocytic Processes Apposed to Synapses to Regulate Intracellular Calcium Signaling. J Neurosci (2015) 0.86

Astroglial glutamate transporters coordinate excitatory signaling and brain energetics. Neurochem Int (2016) 0.86

Lactate shuttling and lactate use as fuel after traumatic brain injury: metabolic considerations. J Cereb Blood Flow Metab (2014) 0.85

Morphological plasticity of astroglia: Understanding synaptic microenvironment. Glia (2015) 0.84

Neuronal influences are necessary to produce mitochondrial co-localization with glutamate transporters in astrocytes. J Neurochem (2014) 0.81

Regulation of brain glutamate metabolism by nitric oxide and S-nitrosylation. Sci Signal (2015) 0.81

Progressive Decrease of Mitochondrial Motility during Maturation of Cortical Axons In Vitro and In Vivo. Curr Biol (2016) 0.79

Mitochondria in complex psychiatric disorders: Lessons from mouse models of 22q11.2 deletion syndrome: Hemizygous deletion of several mitochondrial genes in the 22q11.2 genomic region can lead to symptoms associated with neuropsychiatric disease. Bioessays (2017) 0.78

Displacing hexokinase from mitochondrial voltage-dependent anion channel impairs GLT-1-mediated glutamate uptake but does not disrupt interactions between GLT-1 and mitochondrial proteins. J Neurosci Res (2014) 0.78

Intracellular mGluR5 plays a critical role in neuropathic pain. Nat Commun (2016) 0.78

Compartmentalised energy metabolism supporting glutamatergic neurotransmission in response to increased activity in the rat cerebral cortex: A 13C MRS study in vivo at 14.1 T. J Cereb Blood Flow Metab (2016) 0.77

Subtle modulation of ongoing calcium dynamics in astrocytic microdomains by sensory inputs. Physiol Rep (2015) 0.76

A new role for α-ketoglutarate dehydrogenase complex: regulating metabolism through post-translational modification of other enzymes. J Neurochem (2015) 0.75

The role of astrocyte mitochondria in differential regional susceptibility to environmental neurotoxicants: tools for understanding neurodegeneration. Toxicol Sci (2015) 0.75

The importance of the excitatory amino acid transporter 3 (EAAT3). Neurochem Int (2016) 0.75

Transient Oxygen/Glucose Deprivation Causes a Delayed Loss of Mitochondria and Increases Spontaneous Calcium Signaling in Astrocytic Processes. J Neurosci (2016) 0.75

Developmental changes in trak-mediated mitochondrial transport in neurons. Mol Cell Neurosci (2017) 0.75

Genome-Scale Reconstruction of the Human Astrocyte Metabolic Network. Front Aging Neurosci (2017) 0.75

The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders. NPJ Schizophr (2017) 0.75

How Energy Metabolism Supports Cerebral Function: Insights from (13)C Magnetic Resonance Studies In vivo. Front Neurosci (2017) 0.75

Inhibition of the Mitochondrial Glutamate Carrier SLC25A22 in Astrocytes Leads to Intracellular Glutamate Accumulation. Front Cell Neurosci (2017) 0.75

Articles cited by this

NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41

Glutamate uptake. Prog Neurobiol (2001) 13.59

The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell (2004) 7.45

Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A (1994) 6.96

Sodium/calcium exchange: its physiological implications. Physiol Rev (1999) 5.42

Methods for cell and particle tracking. Methods Enzymol (2012) 4.80

Excitotoxic cell death. J Neurobiol (1992) 4.76

Flux coupling in a neuronal glutamate transporter. Nature (1996) 4.43

The mechanism of Ca2+ -dependent regulation of kinesin-mediated mitochondrial motility. Cell (2009) 4.26

Axonal transport of mitochondria along microtubules and F-actin in living vertebrate neurons. J Cell Biol (1995) 3.74

Axonal mitochondrial transport and potential are correlated. J Cell Sci (2004) 3.15

Synaptic islands defined by the territory of a single astrocyte. J Neurosci (2007) 3.10

The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med (2007) 3.05

Neuron-glia metabolic coupling and plasticity. J Exp Biol (2006) 3.00

Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J Cereb Blood Flow Metab (2006) 2.86

Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron (1995) 2.77

Synaptic activation of glutamate transporters in hippocampal astrocytes. Neuron (1997) 2.75

The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. J Cell Sci (1993) 2.63

The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J Neurosci (2007) 2.60

Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci (2010) 2.55

Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci (1999) 2.50

Moving mitochondria: establishing distribution of an essential organelle. Traffic (2007) 2.44

KIF5C, a novel neuronal kinesin enriched in motor neurons. J Neurosci (2000) 2.43

Control of mitochondrial transport and localization in neurons. Trends Cell Biol (2009) 2.23

New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci (2003) 2.23

Intracellular and trans-synaptic regulation of glutamatergic synaptogenesis by EphB receptors. J Neurosci (2006) 2.17

Extracellular glutamate concentration in hippocampal slice. J Neurosci (2007) 2.13

The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int (2007) 2.11

mGluR5 stimulates gliotransmission in the nucleus accumbens. Proc Natl Acad Sci U S A (2007) 1.77

Mitochondrial trafficking in neurons. Cold Spring Harb Perspect Biol (2013) 1.69

GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia (2008) 1.65

Ballistic labeling and dynamic imaging of astrocytes in organotypic hippocampal slice cultures. J Neurosci Methods (2005) 1.64

Na+ pump low and high ouabain affinity alpha subunit isoforms are differently distributed in cells. Proc Natl Acad Sci U S A (1997) 1.62

Glutamate transporter coupling to Na,K-ATPase. J Neurosci (2009) 1.44

Mitochondrial transport and docking in axons. Exp Neurol (2009) 1.41

Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J Neurosci (2003) 1.39

Role of microtubules and actin filaments in the movement of mitochondria in the axons and dendrites of cultured hippocampal neurons. J Comp Neurol (2000) 1.39

Physiologic coupling of glial glycogen metabolism to neuronal activity in brain. Can J Physiol Pharmacol (1992) 1.33

Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters. Mol Pharmacol (2004) 1.30

Glutamate uptake stimulates Na+,K+-ATPase activity in astrocytes via activation of a distinct subunit highly sensitive to ouabain. J Neurochem (1997) 1.23

Myelination and axonal electrical activity modulate the distribution and motility of mitochondria at CNS nodes of Ranvier. J Neurosci (2011) 1.23

Shaping excitation at glutamatergic synapses. Trends Neurosci (1999) 1.23

Activity-dependent regulation of mitochondrial motility by calcium and Na/K-ATPase at nodes of Ranvier of myelinated nerves. J Neurosci (2010) 1.21

Exogenous glutamate concentration regulates the metabolic fate of glutamate in astrocytes. J Neurochem (1996) 1.21

Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria. J Neurosci (2011) 1.18

Human Myo19 is a novel myosin that associates with mitochondria. Curr Biol (2009) 1.14

ADP regulates movements of mitochondria in neurons. Biophys J (2007) 1.13

Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses. Eur J Neurosci (2010) 1.12

Structural plasticity of perisynaptic astrocyte processes involves ezrin and metabotropic glutamate receptors. Proc Natl Acad Sci U S A (2011) 1.12

Metabolic fate of 14C-labeled glutamate in astrocytes in primary cultures. J Neurochem (1982) 1.11

Mitochondria and neurotransmission: evacuating the synapse. Neuron (2005) 1.10

Investigation of mitochondrial dysfunction by sequential microplate-based respiration measurements from intact and permeabilized neurons. PLoS One (2012) 1.09

Glutamate transport decreases mitochondrial pH and modulates oxidative metabolism in astrocytes. J Neurosci (2011) 1.08

Block of (Na+,K+)ATPase with ouabain induces spreading depression-like depolarization in hippocampal slices. Brain Res (1999) 1.06

Energy metabolism in glutamatergic neurons, GABAergic neurons and astrocytes in primary cultures. Neurochem Res (1988) 1.03

KB-R7943, an inhibitor of the reverse Na+ /Ca2+ exchanger, blocks N-methyl-D-aspartate receptor and inhibits mitochondrial complex I. Br J Pharmacol (2011) 0.99

The glutamate transporter, GLAST, participates in a macromolecular complex that supports glutamate metabolism. Neurochem Int (2012) 0.97

Astrocyte Na+ channels are required for maintenance of Na+/K(+)-ATPase activity. J Neurosci (1994) 0.96

Inhibitors of glutamate dehydrogenase block sodium-dependent glutamate uptake in rat brain membranes. Front Endocrinol (Lausanne) (2013) 0.96

Astrocytic energetics during excitatory neurotransmission: What are contributions of glutamate oxidation and glycolysis? Neurochem Int (2013) 0.94

Altered distribution of mitochondria impairs calcium homeostasis in rat hippocampal neurons in culture. J Neurochem (2003) 0.92

Mechanisms of H+ and Na+ changes induced by glutamate, kainate, and D-aspartate in rat hippocampal astrocytes. J Neurosci (1996) 0.90

Degeneration of astrocytic processes and their mitochondria in cerebral cortical regions peripheral to the cortical infarction: heterogeneity of their disintegration is closely associated with disseminated selective neuronal necrosis and maturation of injury. Stroke (2009) 0.90

In situ fluorescence imaging of glutamate-evoked mitochondrial Na+ responses in astrocytes. Glia (2006) 0.89

Sodium-dependent glutamate uptake as an activator of oxidative metabolism in primary astrocyte cultures from newborn rat. Glia (1995) 0.88

Biolistic transfection of cultured organotypic brain slices. Methods Mol Biol (2004) 0.88

Neuroglia at the crossroads of homoeostasis, metabolism and signalling: evolution of the concept. ASN Neuro (2012) 0.87

Effects of L-glutamate, D-aspartate, and monensin on glycolytic and oxidative glucose metabolism in mouse astrocyte cultures: further evidence that glutamate uptake is metabolically driven by oxidative metabolism. Neurochem Int (2001) 0.85

Demonstration of pyruvate recycling in primary cultures of neocortical astrocytes but not in neurons. Neurochem Res (2002) 0.85

Na(+)-K(+)-ATPase inhibition and depolarization induce glutamate release via reverse Na(+)-dependent transport in spinal cord white matter. Neuroscience (2001) 0.84

Astrocyte metabolism of [15N]glutamine: implications for the glutamine-glutamate cycle. J Neurochem (1988) 0.83

Glutamate-induced ATP synthesis: relationship between plasma membrane Na+/Ca2+ exchanger and excitatory amino acid transporters in brain and heart cell models. Mol Pharmacol (2013) 0.82

Developmental change of GABA(A) receptor-mediated current in rat hippocampus. Neuroscience (2000) 0.81

Sodium-calcium exchanger modulates the L-glutamate Ca(i) (2+) signalling in type-1 cerebellar astrocytes. Adv Exp Med Biol (2013) 0.78

Intracellular targeting of the photoprotein aequorin: A new approach for measuring, in living cells, Ca(2+) concentrations in defined cellular compartments. Cytotechnology (1993) 0.76

Articles by these authors

Astrocytic purinergic signaling coordinates synaptic networks. Science (2005) 6.55

Synaptic islands defined by the territory of a single astrocyte. J Neurosci (2007) 3.10

Low adiponectin levels predict late in-stent restenosis after bare metal stenting in native coronary arteries. Int J Cardiol (2008) 2.78

Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1. Neuron (2009) 2.48

Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med (2006) 2.43

Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci (2010) 2.30

The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int (2007) 2.11

Disrupted dentate granule cell chloride regulation enhances synaptic excitability during development of temporal lobe epilepsy. J Neurosci (2007) 2.00

A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum Gene Ther (2002) 1.96

Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia (2002) 1.91

Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems. J Biol Chem (2007) 1.84

Endogenous nonneuronal modulators of synaptic transmission control cortical slow oscillations in vivo. Proc Natl Acad Sci U S A (2009) 1.76

Massive and specific dysregulation of direct cortical input to the hippocampus in temporal lobe epilepsy. J Neurosci (2006) 1.71

A neuronal glutamate transporter contributes to neurotransmitter GABA synthesis and epilepsy. J Neurosci (2002) 1.69

Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure. J Card Fail (2007) 1.66

Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus. J Neurosci (2007) 1.64

Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus. J Neurosci (2008) 1.63

Hippocampal CA1 circuitry dynamically gates direct cortical inputs preferentially at theta frequencies. J Neurosci (2005) 1.62

Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction. J Am Coll Cardiol (2007) 1.53

Dynamic regulation of synaptic GABA release by the glutamate-glutamine cycle in hippocampal area CA1. J Neurosci (2006) 1.52

Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective. Value Health (2005) 1.50

Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs. J Allergy Clin Immunol (2002) 1.42

Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci (2013) 1.35

Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J Neurochem (2006) 1.35

Region-directed phototransfection reveals the functional significance of a dendritically synthesized transcription factor. Nat Methods (2006) 1.34

Repeated neonatal handling with maternal separation permanently alters hippocampal GABAA receptors and behavioral stress responses. Proc Natl Acad Sci U S A (2003) 1.28

AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes. J Neurochem (2002) 1.27

Dentate granule cell GABA(A) receptors in epileptic hippocampus: enhanced synaptic efficacy and altered pharmacology. Eur J Neurosci (2003) 1.26

Behavioral and neurochemical alterations in mice lacking the RNA-binding protein translin. J Neurosci (2006) 1.25

In vitro functional imaging in brain slices using fast voltage-sensitive dye imaging combined with whole-cell patch recording. Nat Protoc (2008) 1.25

Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1. Glia (2010) 1.25

Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population. Am J Manag Care (2005) 1.22

Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PLoS One (2011) 1.21

Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol (2006) 1.21

Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria. J Neurosci (2011) 1.18

Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies. Biomaterials (2007) 1.17

Bidirectional astrocyte-neuron communication: the many roles of glutamate and ATP. Novartis Found Symp (2006) 1.16

Protein kinase C activation decreases cell surface expression of the GLT-1 subtype of glutamate transporter. Requirement of a carboxyl-terminal domain and partial dependence on serine 486. J Biol Chem (2002) 1.15

Rapid trafficking of the neuronal glutamate transporter, EAAC1: evidence for distinct trafficking pathways differentially regulated by protein kinase C and platelet-derived growth factor. J Biol Chem (2004) 1.14

Hippocampal microcircuit dynamics probed using optical imaging approaches. J Physiol (2011) 1.14

Deterministic and stochastic neuronal contributions to distinct synchronous CA3 network bursts. J Neurosci (2012) 1.14

Real-time monitoring of coronary care mortality: a comparison and combination of two monitoring tools. Int J Cardiol (2005) 1.09

Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia (2002) 1.08

Shift of intracellular chloride concentration in ganglion and amacrine cells of developing mouse retina. J Neurophysiol (2005) 1.05

High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome. Circ J (2007) 1.04

Caveolin-1 regulates the delivery and endocytosis of the glutamate transporter, excitatory amino acid carrier 1. J Biol Chem (2007) 1.03

Identification of motifs involved in endoplasmic reticulum retention-forward trafficking of the GLT-1 subtype of glutamate transporter. J Neurosci (2004) 1.02

Constitutive endocytosis and recycling of the neuronal glutamate transporter, excitatory amino acid carrier 1. J Neurochem (2007) 0.97

Impaired glutamate transport in a mouse model of tau pathology in astrocytes. J Neurosci (2006) 0.97

Protracted postnatal development of sparse, specific dentate granule cell activation in the mouse hippocampus. J Neurosci (2013) 0.97

The glutamate transporter, GLAST, participates in a macromolecular complex that supports glutamate metabolism. Neurochem Int (2012) 0.97

Internalization and degradation of the glutamate transporter GLT-1 in response to phorbol ester. Neurochem Int (2007) 0.96

Inhibitors of glutamate dehydrogenase block sodium-dependent glutamate uptake in rat brain membranes. Front Endocrinol (Lausanne) (2013) 0.96

Ubiquitination-mediated internalization and degradation of the astroglial glutamate transporter, GLT-1. Neurochem Int (2008) 0.95

Nuclear factor-κB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes. J Neurosci (2011) 0.95

Reactivation of brain acetylcholinesterase by monoisonitrosoacetone increases the therapeutic efficacy against nerve agents in guinea pigs. Chem Biol Interact (2010) 0.94

Axonal α7 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutons. Proc Natl Acad Sci U S A (2010) 0.93

Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-alpha-treated cardiomyocytes in association with improved glucose uptake. Am J Physiol Heart Circ Physiol (2007) 0.93

Behavioral changes and dopaminergic dysregulation in mice lacking the nuclear receptor Rev-erbα. Mol Endocrinol (2014) 0.92

The endoplasmic reticulum exit of glutamate transporter is regulated by the inducible mammalian Yip6b/GTRAP3-18 protein. J Biol Chem (2007) 0.92

Axon regeneration in the absence of growth cones: acceleration by cyclic AMP. J Comp Neurol (2009) 0.91

Evidence that protein kinase Calpha interacts with and regulates the glial glutamate transporter GLT-1. J Neurochem (2005) 0.90

Protein kinase C-dependent remodeling of glutamate transporter function. Mol Interv (2004) 0.90

Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome. J Cardiovasc Pharmacol (2008) 0.90

Rottlerin, an inhibitor of protein kinase Cdelta (PKCdelta), inhibits astrocytic glutamate transport activity and reduces GLAST immunoreactivity by a mechanism that appears to be PKCdelta-independent. J Neurochem (2003) 0.90

Neurotransmitter transporters: why dance with so many partners? Curr Opin Pharmacol (2004) 0.90

Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction. J Am Coll Cardiol (2006) 0.89

Phorbol myristate acetate-dependent interaction of protein kinase Calpha and the neuronal glutamate transporter EAAC1. J Neurosci (2003) 0.88

In vivo reactivation by oximes of inhibited blood, brain and peripheral tissue cholinesterase activity following exposure to nerve agents in guinea pigs. Chem Biol Interact (2010) 0.88

A carboxyl-terminal determinant of the neuronal glutamate transporter, EAAC1, is required for platelet-derived growth factor-dependent trafficking. J Biol Chem (2005) 0.87

Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial. Eur J Cardiovasc Prev Rehabil (2005) 0.87

Evidence that Akt mediates platelet-derived growth factor-dependent increases in activity and surface expression of the neuronal glutamate transporter, EAAC1. Neuropharmacology (2005) 0.86

Gauging the treatment gap in dyslipidemia: findings from the 1999-2000 National Health and Nutrition Examination Survey. Am Heart J (2005) 0.86

Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis. J Am Coll Cardiol (2005) 0.86

N-methyl-D-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1. J Biol Chem (2007) 0.86

Developmental and cell-selective variations in N-methyl-D-aspartate receptor degradation by calpain. J Neurochem (2006) 0.86

Circulating hepatocyte growth factor as a diagnostic marker of thrombus formation in patients with cerebral infarction. Circ J (2002) 0.85

Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia. Atherosclerosis (2006) 0.85

Engraftment of nonintegrating neural stem cells differentially perturbs cortical activity in a dose-dependent manner. Mol Ther (2013) 0.85

A dominant-negative variant of SNAP-23 decreases the cell surface expression of the neuronal glutamate transporter EAAC1 by slowing constitutive delivery. Neurochem Int (2006) 0.85

The incorporation of an ion channel gene mutation associated with the long QT syndrome (Q9E-hMiRP1) in a plasmid vector for site-specific arrhythmia gene therapy: in vitro and in vivo feasibility studies. Hum Gene Ther (2003) 0.85

Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Atherosclerosis (2005) 0.84

Regulation of the neuronal glutamate transporter excitatory amino acid carrier-1 (EAAC1) by different protein kinase C subtypes. Mol Pharmacol (2002) 0.84

Two-year retrospective economic evaluation of three dual-controller therapies used in the treatment of asthma. Chest (2002) 0.84

Differential regulation of GLAST immunoreactivity and activity by protein kinase C: evidence for modification of amino and carboxyl termini. J Neurochem (2004) 0.84

Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats. Eur J Pharmacol (2005) 0.83

Clioquinol effects on tissue chelatable zinc in mice. J Mol Med (Berl) (2003) 0.83

Genetic diversity of the Japanese wood pigeon, Columba janthina, endemic to islands of East Asia, estimated by newly developed microsatellite markers. Zoolog Sci (2011) 0.82

mRNA for the EAAC1 subtype of glutamate transporter is present in neuronal dendrites in vitro and dramatically increases in vivo after a seizure. Neurochem Int (2010) 0.81

Patterns and effectiveness of lipid-lowering therapies in a managed care environment. Value Health (2005) 0.81

Treatment with tertiary oximes prevents seizures and improves survival following sarin intoxication. J Mol Neurosci (2009) 0.81

Increased ambulatory pulse pressure is a strong risk factor for coronary endothelial vasomotor dysfunction. J Am Coll Cardiol (2005) 0.80

High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis. Atherosclerosis (2008) 0.80

Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose. Toxicol Mech Methods (2009) 0.80